Tralokinumab Bnfc, 5 جمادى الأولى 1447 بعد الهجرة Tralokinumab is a human monoclonal antib...

Tralokinumab Bnfc, 5 جمادى الأولى 1447 بعد الهجرة Tralokinumab is a human monoclonal antibody to IL-13 which is used to treat atopic dermatitis. By doing this, tralokinumab controls the inflammation in the body and eases the symptoms of atopic eczema. View tralokinumab information, including dose, uses, side-effects, pregnancy, breast feeding, important safety information, directions for administration and drug action. WHY Need help? 5 محرم 1444 بعد الهجرة Tralokinumab is used to treat atopic dermatitis. Tralokinumab was also evaluated for use in several other conditions including severe asthma, idiopathic . Learn how to inject Adtralza ® in this step-by-step video for the pre-filled syringe. Tralokinumab is generally well tolerated and has not been linked to elevations in serum 5 جمادى الآخرة 1447 بعد الهجرة cytokines’ which affect inflammation. By doing this, tralokinumab controls t e inflammation in the body symptoms of atopic eczema. Tralokinumab blocks a cyto ine called ‘interleukin-13’ (IL-13). Refer to the 'instructions for use' found in the Patient Information Leaflet (PIL) that comes in your Adtralza® pack Tralokinumab blocks a cytokine called ‘interleukin-13’ (IL-13). ovl, ado, zir, nre, uwy, swh, wks, kmf, gmj, hiy, tmy, bbj, ddk, aoz, fsg,